Studies demonstrating the efficacy of correcting an enzyme deficiency in Sjogren-Larsson syndrome by delivering the fatty aldehyde dehydrogenase (FALDH) gene using AAV vectors have become an important proof of concept [10]. The gene discussed is ALDH3A2; the disease is Sjogren-Larsson syndrome.